← Back to Search

Hemorrhage for Subarachnoid Hemorrhage

N/A
Waitlist Available
Led By Bobby M Agrawal, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to investigate if brain oxygen levels, levels of a specific protein in the cerebrospinal fluid and blood (Cleaved-tau protein), and brain blood flow can predict spasm of brain blood vessels after bleeding in the brain from a ruptured aneurysm.

Eligible Conditions
  • Subarachnoid Hemorrhage
  • Cerebral Vasospasm

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: HemorrhageExperimental Treatment3 Interventions
Patients having experienced subarachnoid hemorrhage and have in place a ventriculostomy

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,232 Previous Clinical Trials
3,199,914 Total Patients Enrolled
1 Trials studying Subarachnoid Hemorrhage
11 Patients Enrolled for Subarachnoid Hemorrhage
Bobby M Agrawal, MDPrincipal InvestigatorUniversity of Wisconsin Department of Neurosurgery
Mustafa Baskaya, MDPrincipal InvestigatorUniversity of Wisconsin Department of Neurosurgery
~1 spots leftby Nov 2025